Impaired growth response to endothelin-1 in scleroderma fibroblasts

K Kikuchi1, T Kadono, S Sato

  • 1Department of Dermatology, University of Tokyo Branch Hospital, Japan.

Insights

Systemic sclerosis (SSc) involves vascular damage and fibrosis. This study found reduced endothelin ETA receptor expression in SSc fibroblasts, explaining their diminished growth response to endothelin-1.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Cell Biology

Background:

  • Systemic sclerosis (SSc) is a fibrotic disease marked by vascular damage.
  • Endothelin (ET) signaling plays a role in fibroblast proliferation.

Purpose of the Study:

  • To investigate the endothelin (ET) receptor subtype mediating mitogenic signaling in scleroderma and normal skin fibroblasts.
  • To compare ET-1 and ET-3 effects on fibroblast DNA synthesis.

Main Methods:

  • Fibroblast cultures from scleroderma and normal skin were used.
  • DNA synthesis was measured after ET-1 and ET-3 stimulation.
  • Endothelin ETA receptor binding and expression (mRNA and protein) were analyzed.

Main Results:

  • ET-1 stimulated DNA synthesis in normal fibroblasts; ET-3 had lesser effects.
  • Scleroderma fibroblasts showed a decreased growth response to ET-1 compared to normal fibroblasts.
  • Scleroderma fibroblasts exhibited significantly decreased [125I]-ET-1 binding and diminished ETA receptor expression (protein and mRNA) compared to normal controls.

Conclusions:

  • Mitogenic effects of ET in human dermal fibroblasts are primarily mediated through ETA receptors.
  • Down-regulation of ETA receptors in scleroderma fibroblasts leads to a decreased growth response to ET-1.